Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Thrombosis

Congenital heart disease and thrombosis: what do we know?

A scientific statement on the prevention and treatment of thrombosis in children with congenital heart disease has been published by Giglia et al. on behalf of the AHA. This paper adds substantially to the current literature, and yet highlights the major limitations in our current understanding and knowledge in this field.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Chronic venous insufficiency associated with thomboembolism (post-thrombotic syndrome) in a 13-year-old, female, long-term survivor of Fontan surgery.

References

  1. 1

    Giglia, T. M. et al. Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation 128, 2622–2703 (2013).

    Article  Google Scholar 

  2. 2

    Monagle, P. et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141, e737S–e801S (2012).

    CAS  Article  Google Scholar 

  3. 3

    National Heart, Lung, and Blood Institute. Working Group/Workshop Executive Summary. Thrombosis in Pediatric Cardiology and Adult Congenital Heart Disease [online], (2012).

  4. 4

    Fontan, F. & Baudet, E. Surgical repair of tricuspid atresia. Thorax 26, 240–248 (1971).

    CAS  Article  Google Scholar 

  5. 5

    Murdoch Childrens Research Institute. Fontan Registry [online], (2013).

  6. 6

    Sistino, J. J. & Bonilha, H. S. Improvements in survival and neurodevelopmental outcomes in surgical treatment of hypoplastic left heart syndrome: a meta-analytic review. J. Extra Corpor. Technol. 44, 216–223 (2012).

    PubMed  PubMed Central  Google Scholar 

  7. 7

    Monagle, P. Anticoagulation in the young. Heart 90, 808–812 (2004).

    Article  Google Scholar 

  8. 8

    Chan, A. K. & Monagle, P. Updates in thrombosis in pediatrics: where are we after 20 years? Hematology Am. Soc. Hematol. Educ. Program 2012, 439–443 (2012).

    PubMed  Google Scholar 

  9. 9

    Andrew, M. et al. Venous thromboembolic complications (VTE) in children: first analysis of the Canadian Registry of VTE. Blood 83, 1251–1257 (1994).

    CAS  PubMed  Google Scholar 

  10. 10

    Monagle, P. et al. A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. J. Am. Coll. Cardiol. 58, 645–651 (2011).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Paul Monagle.

Ethics declarations

Competing interests

The author declares no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Monagle, P. Congenital heart disease and thrombosis: what do we know?. Nat Rev Cardiol 11, 132–134 (2014). https://doi.org/10.1038/nrcardio.2013.217

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing